Article
Role of blood metabolites in mediating the effect of gut microbiome on the mutated-RAS/BRAF metastatic colorectal cancer-specific survival.
International journal of colorectal disease - 24 Jul 2024
Xiang Yaoxian, Zhang Chan, Wang Jing, Cheng Yurong, Wang Kangjie, Wang Li, Tong Yingying, Yan Dong
Abstract excerpt
BACKGROUND: Recent studies have linked alterations in the gut microbiome and metabolic disruptions to the invasive behavior and metastasis of colorectal cancer (CRC), thus affecting patient prognosis. However, the specific relationship among gut microbiome, metabolite profiles, and mutated-RAS/BRAF metastatic colorectal cancer (M-mCRC) remains unclear. Furthermore, the potential mechanisms and prognostic...
Topics
Join the communities discussing this publication.
